Skip to main content
CRVS logo

CRVS · Corvus Pharmaceuticals, Inc. · Holdings

Track CRVS — free
$10.40 +0.19 (+1.86%)
Market Cap
$830.27M
Shares
84.12M
Volume · Oct 8 1.88M Avg daily vol (3M) 987.58K

Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.

Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.
The Sep 30, 2026 filing window is still open — showing the latest known positions. Funds that have not filed yet carry their prior-quarter positions; a fund that filed without this stock counts as sold out. Each fund's Change is measured against its own previous reported quarter, shown in the Reported column. Pick a completed quarter in the Quarter selector below to put every fund on one quarter and see the stock-wide activity breakdown.
Holders: 174
Total Value: $1,088,914,284
Total Shares: 72,886,135
Showing 1–100 of 185 holdings by value · page 1 of 2

Institutional Ownership Trend

27 quarters

Holder Concentration

Across 174 13F filers
Top Holder
9.8%
Sep 2023 → Jun 2026 · range 9.8% – 38.7%
of institutional value
Top 5
35.5%
Sep 2023 → Jun 2026 · range 32.6% – 86.7%
of institutional value
Top 10
54.6%
Sep 2023 → Jun 2026 · range 50.8% – 95.2%
of institutional value
HHI
410
Sep 2023 → Jun 2026 · range 379 – 2,109
Broadly held
Showing 100 of 185
Export CSV
Holder Value (USD) % of 13F Shares Open
Key facts CIK 1626971 CUSIP 221015100 13F (30d) 6 filings 6 filers Visit website Investor relations